New Immunotherapy Clinical Trial Uses Modified Poliovirus Against Glioblastoma | Brain Tumor Center
The UCSF Brain Tumor Center is one of four sites in the country testing a modified version of a poliovirus that had encouraging results against glioblastoma (GBM) in a recent phase I clinical trial.
